Aims Studies have indicated that chloroquine (CQ) shows antagonism against COVID-19 in
vitro. However, evidence regarding its effects in patients is limited. This study aims to …

Abstract Background and Objective The world is currently experiencing the Coronavirus
Disease-19 (COVID-19) pandemic. There is no approved drug for the definitive treatment of …

Background Hydroxychloroquine and chloroquine have been proposed as treatments for
coronavirus disease 2019 (Covid-19) on the basis of in vitro activity and data from …

Abstract Purpose COVID-19 (coronavirus disease 2019) is a public health emergency of
international concern. As of this time, there is no known effective pharmaceutical treatment …

Background On the 11 March 2020, the World Health Organization (WHO) declared that
COVID-19 was a pandemic. To date, there are no medical treatments for COVID-19 with …

Objective In this study, we evaluated the efficacy of hydroxychloroquine (HCQ) against
coronavirus disease 2019 (COVID-19) via a randomized controlled trial (RCT) and a …

Effective therapies are urgently needed for the SARS-CoV-2 pandemic. Chloroquine has
been proved to have antiviral effect against coronavirus in vitro. In this study, we aimed to …

Despite several studies designed to evaluate the efficacy of chloroquine and
hydroxychloroquine in the treatment of coronavirus disease 2019 (COVID-19), there is still …

The COVID-19 pandemic is showing an exponential growth, mandating an urgent need to
develop an effective treatment. Indeed, to date, a well-established therapy is still lacking. We …

Objective To evaluate the efficacy and safety of hydroxychloroquine (HCQ) in the treatment
of patients with moderate coronavirus disease 2019 (COVID-19). Methods We prospectively …